The ENABLE Study: Safety and Efficacy Study of INZ-701 in Patients With ENPP1 Deficiency

Clinical trial NCT06739980 · WITHDRAWN

Trial details

NCT number: NCT06739980
Sponsor: Inozyme Pharma
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency Autosomal Recessive Hypophosphatemic Rickets Generalized Arterial Calcification of Infancy 1

Start date: 2025-01-31
Primary completion: 2027-03-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.